Your browser doesn't support javascript.
loading
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial.
Marlow, Neil; Stahl, Andreas; Lepore, Domenico; Fielder, Alistair; Reynolds, James D; Zhu, Qi; Weisberger, Annemarie; Stiehl, Daniel P; Fleck, Brian.
Affiliation
  • Marlow N; UCL Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK. Electronic address: n.marlow@ucl.ac.uk.
  • Stahl A; Department of Ophthalmology, University Medical Center Greifswald, Greifswald, Germany.
  • Lepore D; Department of Ophthalmology, Gemelli Foundation IRCSS, Catholic University of the Sacred Heart, Rome, Italy.
  • Fielder A; Department of Optometry and Visual Science, City, University of London, London, UK.
  • Reynolds JD; Ross Eye Institute, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, USA.
  • Zhu Q; China Novartis Institutes for BioMedical Research Company, Shanghai, China.
  • Weisberger A; Ophthalmology Development Unit, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Stiehl DP; Novartis Pharma, Basel, Switzerland.
  • Fleck B; Royal Hospital for Sick Children, University of Edinburgh, Edinburgh, UK.
Lancet Child Adolesc Health ; 5(10): 698-707, 2021 10.
Article in En | MEDLINE | ID: mdl-34391532
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinopathy of Prematurity / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Laser Therapy / Ranibizumab Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Child, preschool / Female / Humans / Infant / Male Language: En Journal: Lancet Child Adolesc Health Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Retinopathy of Prematurity / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Laser Therapy / Ranibizumab Type of study: Clinical_trials / Observational_studies / Prognostic_studies Limits: Child, preschool / Female / Humans / Infant / Male Language: En Journal: Lancet Child Adolesc Health Year: 2021 Type: Article